Search results for "Angiogenesis modulators"

showing 1 items of 1 documents

Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology

2019

Osteonecrosis of the jaw (ONJ) is a well-known pathological condition in oncology derived from the use of bisphosphonates (BPs) and denosumab. Many molecular and immunological targets have been introduced for daily use in cancer treatment in recent years; consequently, new cases of ONJ have been reported in association with these drugs, especially if administered with BPs and denosumab. When the drugs are administered alone, ONJ is rarely seen. The objective of our study was to analyze the recent literature relative to the association of ONJ with these new drugs highlighting the pathogenic, clinical and therapeutic aspects. The close collaboration between maxillofacial surgeon, oncologist, …

Oncologymedicine.medical_specialtymedicine.medical_treatmentOdontologíaReview ArticleMaxilaresTargeted therapyOncologíaImmunomodulation03 medical and health sciences0302 clinical medicineInternal medicinemedicineOral manifestations030223 otorhinolaryngologyBonePathologicalbusiness.industryGénéralités030206 dentistryImmunotherapyCáncermedicine.diseaseCancer treatmentDenosumabSurgeryOral SurgeryOsteonecrosis of the jawbusinessAngiogenesis modulatorsInfectionmedicine.drug
researchProduct